A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Ir-CPI in Healthy Male Subjects
Clinical trial NCT04653766 · COMPLETED
Trial details
- NCT number
- NCT04653766
- Sponsor
- Bioxodes S.A.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-12
- Primary completion
- 2020-07-18
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.